The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase III trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC).
 
Mary-Ellen Taplin
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Celgene; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Merck; Pfizer; Progenics; Research to Practice; UpToDate
Consulting or Advisory Role - AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Bayer (Inst); Janssen-Ortho (Inst); Medivation (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen Oncology; Medivation; Pfizer; Tokai Pharmaceuticals
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Astellas Pharma; Bayer; Genova Diagnostics; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427; ST-CP; ST-POP
 
Christopher P. Evans
Stock and Other Ownership Interests - Exelixis
Honoraria - Astellas Pharma; Janssen Oncology; Pfizer
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MDxHealth
Speakers' Bureau - Astellas Pharma; Janssen Oncology; MDXHealth; Pfizer
Research Funding - Astellas Pharma; Ferring; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Sanofi; Tolmar
Research Funding - Astellas Pharma; Bayer; Janssen; Sanofi; Tolmar
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Sanofi; Tolmar
 
Philip W. Kantoff
Leadership - Context Therapeutics
Stock and Other Ownership Interests - Context Therapeutics; Druggablity Technologies; Placon; Seer; Tarveda Therapeutics
Consulting or Advisory Role - Bavarian Nordic; Context Therapeutics; Druggablity Technologies; GE Healthcare; Genentech/Roche; Janssen; Merck; New England Research Institutes; OncoCellMDX; Progenity; Sanofi; Seer; Tarveda Therapeutics; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Chromosome Copy Number Gain as a Biomarker of Urothelial Carcinoma Lethality; Composition and Methods for Screening and Diagnosis of Prostate Cancer; Drug Combinations to Treat Cancer; Method for Predicting the Risk of Prostate Cancer Morbidity and Mortality; Methods and Kits for Determining Sensitivity to Cancer Treatment; Methods for Predicting Likelihood of Responding to Treatment; Predicting and Treating Prostate Cancer; Somatic ERCC2 Mutations Correlate with Cisplatin sensitivity in muscle-invasive Urothelial Carcinoma (Patent); Up-to-Date Royalties; Wolters Kluwer Royalties
Travel, Accommodations, Expenses - Druggablity Technologies
 
Ashley Ross
Stock and Other Ownership Interests - GenomeDx
Honoraria - Bayer; Healthtronics
Consulting or Advisory Role - Blue Earth Diagnostics; Healthtronics
Speakers' Bureau - Blue Earth Diagnostics; Johnson & Johnson; Tempus
Research Funding - metamark genetics
 
Neal D. Shore
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Merck; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; Ferring; Janssen-Cilag; MDxHealth; OPKO Health
Research Funding - Sandoz-Novartis
 
Boris A. Hadaschik
Consulting or Advisory Role - Bayer; Janssen; Lightpoint medical
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; Sanofi
 
Oliver Brendan Rooney
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Shaozhou Ken Tian
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Patent for making cell blocks in cytology.
Travel, Accommodations, Expenses - Janssen Oncology
 
Lisa Wetherhold
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Weichun Xu
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Shinta Cheng
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Patent under Bristol Myers Squibb company (Inst)
 
Sabine Doris Brookman-May
Employment - Janssen Research & Development
Leadership - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Janssen Research & Development
 
Angela Lopez-Gitlitz
No Relationships to Disclose
 
Adam S. Kibel
Honoraria - InSightec; Janssen; Merck; profound
Consulting or Advisory Role - Bristol-Myers Squibb